Practices reported by incarcerated drug abusers to reduce risk of AIDS. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Practices reported by incarcerated drug abusers to reduce risk of AIDS.

Hosp Community Psychiatry. 1988 Sep;39(9):966-72. Unique Identifier : AIDSLINE MED/89108349
Valdiserri EV; Hartl AJ; Chambliss CA; Lenape Valley Foundation, Doylestown, Pennsylvania.

Abstract: The nation's response to AIDS has failed to effectively curb the spread of AIDS among intravenous (IV) drug users, who are primarily responsible for transmitting the disease to heterosexuals and children. A study assessing awareness of AIDS among 58 county jail inmates--27 IV drug abusers and 31 nonintravenous drug abusers--found that a minority had received formal AIDS education. All of the subjects claimed to be taking some precautions against AIDS, but IV drug abusers were significantly more fearful about contracting AIDS than were nonintravenous users. Less than half of either group knew that asymptomatic carriers of the AIDS virus were infectious. IV drug users who reported no longer sharing needles (56 percent) or no longer shooting drugs (22 percent) were more likely than those who took less effective precautions to believe that individuals had control over events. County jails and other correctional institutions are urged to educate inmates about AIDS prevention.
Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/ TRANSMISSION Adult Female *Health Behavior Health Education/METHODS Human Injections, Intravenous Male Prisoners/*PSYCHOLOGY Risk Factors Substance Abuse/*COMPLICATIONS JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDprevention&control/transmissionadultfemaleKWDhealthbehaviorhealtheducation/methodshumaninjections,intravenousmaleprisoners/KWDpsychologyriskfactorssubstanceabuse/KWDcomplicationsjournalarticle
890530
M8950626

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .